Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-68.76	31.83	101.89
Graham Fair Price	-17.65	123.87	150.43
PEG	66.20	-0.89	0.53
Price/Book	6.00	4.11	3.88
Price/Cash Flow	-0.20	21.95	21.99
Prices/Earnings	45.37	26.42	18.18
Price/Sales	-3.36	13.38	13.84
Price/FCF	-0.20	21.95	21.99
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	46.84	0.99	0.67
Operating Margin	203.37	0.72	0.24
ROA	-35.43	< 0.005	0.01
ROE	0.05	0.04	-27.08
ROIC	0.01	0.04	175.42
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.11	0.03	318.63
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.21	2.13	935.26
EPS QOQ	0.34	-0.30	-12.54
FCF QOQ	-0.01	< 0.005	-94.94
Revenue QOQ	0.04	0.03	-14.21
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	527.52	0.00	inf
Days Sales Outstanding (DSO)	1274.13	1.97	-99.85
Inventory Turnover	0.17	0.00	inf
Debt/Capitalization	0.75	0.77	3.60
Quick Ratio	17.67	1.42	-91.99
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	137.27	132.38	-3.56
Cash	8.33	45.85	450.57
Capex	-0.13	-0.02	81.94
Free Cash Flow	24.23	24.81	2.43
Revenue	38.48	40.70	5.77
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	18.60	19.24	3.40
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	43.42	13.56	-68.77
Naive Interpretation	Member

06 - Financial Health · Bad

Rating